Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Muscle-invasive Bladder Cancer
×
tremelimumab
×
Clear all
Filters
3
NCT03234153
2020-06-17
NITIMIB
Insel Gruppe AG, University Hospital Bern
Phase 2
Terminated
6 enrolled